Tixagevimab-Cilgavimab: Utilization in the solid organ transplant population

被引：0
|
作者：
Shaikh, Suhail A. [1 ]
Morado, Faiza [2 ]
Kawewat-Ho, Pnada [1 ]
Cartus, Rachel [1 ]
Davoudi, Roland [1 ]
Forrester, Kevin [3 ]
Azizian, Krist [3 ]
Blodget, Emily [4 ]
Maw, Thin Thin [4 ]
Nanda, Neha [4 ]
机构：
[1] Univ Southern Calif, USC Transplant Inst, Keck Hosp USC, 1516 San Pablo S 32269, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Dept Clin Pharm, Keck Hosp USC, Los Angeles, CA 90007 USA
[3] Univ Southern Calif, Hlth Sci Ctr, Dept Clin Pharm, Los Angeles, CA 90007 USA
[4] Univ Southern Calif, Dept Med, Keck Med Ctr, Los Angeles, CA USA
来源：
CLINICAL TRANSPLANTATION | 2022年 / 36卷 / 06期
关键词：
D O I：
10.1111/ctr.14661
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Investigation of severe acute respiratory syndrome coronavirus 2 infection status in solid organ transplant recipients treated with tixagevimab/ cilgavimab
    Aihara, Ririka
    Umemura, Keisuke
    Katada, Yoshiki
    Nakagawa, Shunsaku
    Kobayashi, Takashi
    Hatano, Etsuro
    Date, Hiroshi
    Nagao, Miki
    Terada, Tomohiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (12) : 1222 - 1227
  • [22] REAL-WORLD EFFECTIVENESS AND SAFETY OF TIXAGEVIMAB-CILGAVIMAB: A TARGET TRIAL EMULATION STUDY
    Yan, V
    Yang, Y.
    Wan, E. Y. F.
    Yiu, H. H. E.
    Wong, I. C. K.
    Chan, E. W.
    VALUE IN HEALTH, 2023, 26 (12) : S221 - S221
  • [23] Tixagevimab-Cilgavimab for Breakthrough COVID-19 Prevention in Dialysis Patients: A Prospective Study
    Sritippayawan, Suchai
    Boongird, Sarinya
    Srithongkul, Thatsaphan
    Sethakarun, Sethanant
    Bruminhent, Jackrapong
    Kiertiburanakul, Sasisopin
    Nongnuch, Arkom
    Kitiyakara, Chagriya
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [24] Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation Study
    Yan, Vincent Ka Chun
    Yang, Yu
    Wan, Eric Yuk Fai
    Lai, Francisco Tsz Tsun
    Chui, Celine Sze Ling
    Li, Xue
    Wong, Carlos King Ho
    Hung, Ivan Fan Ngai
    Lau, Chak Sing
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    DRUG SAFETY, 2024, 47 (10) : 1025 - 1037
  • [25] Nephrotic-range proteinuria: a potential risk factor for failure of tixagevimab-cilgavimab prophylaxis
    Al Jurdi, Ayman
    El Mouhayyar, Christopher
    Efe, Orhan
    Jeyabalan, Anushya
    Riella, Leonardo V.
    JOURNAL OF NEPHROLOGY, 2024, 37 (01) : 141 - 147
  • [26] Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective study
    Boongird, Sarinya
    Srithongkul, Thatsaphan
    Sethakarun, Sethanant
    Bruminhent, Jackrapong
    Kiertiburanakul, Sasisopin
    Nongnuch, Arkom
    Kitiyakara, Chagriya
    Sritippayawan, Suchai
    CLINICAL KIDNEY JOURNAL, 2024, 17 (11)
  • [27] Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence
    Manuela Altieri
    Rosario Domenico Melisi
    Miriana Conte
    Rocco Capuano
    Giovanna Donnarumma
    Elena Grimaldi
    Nicola Coppola
    Stefania De Pascalis
    Mario Risi
    Alessandro d’Ambrosio
    Alvino Bisecco
    Antonio Gallo
    Neurological Sciences, 2023, 44 : 4107 - 4110
  • [28] Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients
    Angelico, Roberta
    Romano, Francesca
    Coppola, Luigi
    Materazzo, Marco
    Pedini, Domiziana
    Santicchia, Maria Sara
    Cacciola, Roberto
    Toti, Luca
    Sarmati, Loredana
    Tisone, Giuseppe
    MEDICINA-LITHUANIA, 2023, 59 (12):
  • [29] Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimab for coronavirus disease 2019
    Montastruc, Francois
    Lafaurie, Margaux
    Flumian, Clara
    de Canecaude, Claire
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (04) : 543e1 - 543e3
  • [30] COVID-19 morbidity decreases with tixagevimab-cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
    Kaminski, Hannah
    Gigan, Mickael
    Vermorel, Agathe
    Charrier, Manon
    Guirle, Laura
    Jambon, Frederic
    Lacapere, Arthur
    Menard, Coline
    Moreau, Karine
    Neau-Cransac, Martine
    Novion, Marine
    Pribat, Frederique
    Borde, Sebastien
    Burguet, Laure
    Taton, Benjamin
    Martinez, Charlie
    Jasiek, Magali
    D'Halluin, Pauline
    Lafon, Marie-Edith
    Merville, Pierre
    Couzi, Lionel
    KIDNEY INTERNATIONAL, 2022, 102 (04) : 936 - 938
12345